In Silico Modelling of Treatment-induced Tumour Cell Kill: Developments and Advances

Overview

Journal Comput Math Methods Med

Publisher Hindawi

Specialty Medical Informatics

Date 2012 Aug 2

PMID 22852024

Citations 12

Authors

Loredana G Marcu

Wendy M Harriss-Phillips

Affiliations

Soon will be listed here.

Abstract

Mathematical and stochastic computer (in silico) models of tumour growth and treatment response of the past and current eras are presented, outlining the aims of the models, model methodology, the key parameters used to describe the tumour system, and treatment modality applied, as well as reported outcomes from simulations. Fractionated radiotherapy, chemotherapy, and combined therapies are reviewed, providing a comprehensive overview of the modelling literature for current modellers and radiobiologists to ignite the interest of other computational scientists and health professionals of the ever evolving and clinically relevant field of tumour modelling.

Citing Articles

A comprehensive review of computational cell cycle models in guiding cancer treatment strategies.

Ma C, Gurkan-Cavusoglu E NPJ Syst Biol Appl. 2024; 10(1):71.

PMID: 38969664 PMC: 11226463. DOI: 10.1038/s41540-024-00397-7.

Models for Translational Proton Radiobiology-From Bench to Bedside and Back.

Suckert T, Nexhipi S, Dietrich A, Koch R, Kunz-Schughart L, Bahn E Cancers (Basel). 2021; 13(16).

PMID: 34439370 PMC: 8395028. DOI: 10.3390/cancers13164216.

In Silico Mathematical Modelling for Glioblastoma: A Critical Review and a Patient-Specific Case.

Falco J, Agosti A, Vetrano I, Bizzi A, Restelli F, Broggi M J Clin Med. 2021; 10(10).

PMID: 34067871 PMC: 8156762. DOI: 10.3390/jcm10102169.

The Ever-Changing Role of Medical Physicists in the Era of Personalized Medicine.

Marcu L J Med Phys. 2021; 45(4):197-198.

PMID: 33953493 PMC: 8074720. DOI: 10.4103/jmp.JMP_113_20.

Optimization of Dose Schedules for Chemotherapy of Early Colon Cancer Determined by High-Performance Computer Simulations.

Cockrell C, Axelrod D Cancer Inform. 2019; 18:1176935118822804.

PMID: 30675100 PMC: 6330731. DOI: 10.1177/1176935118822804.

References

McElwain D, Callcott R, Morris L . A model of vascular compression in solid tumours. J Theor Biol. 1979; 78(3):405-15. DOI: 10.1016/0022-5193(79)90339-4. View

Keall P, Webb S . Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution. Phys Med Biol. 2006; 52(1):291-302. DOI: 10.1088/0031-9155/52/1/019. View

Maseide K, Rofstad E . Mathematical modeling of chronical hypoxia in tumors considering potential doubling time and hypoxic cell lifetime. Radiother Oncol. 2000; 54(2):171-7. DOI: 10.1016/s0167-8140(99)00154-1. View

Marcu L, van Doorn T, Olver I . Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas. Phys Med Biol. 2004; 49(16):3767-79. DOI: 10.1088/0031-9155/49/16/021. View

Marcu L, Bezak E, Olver I . Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach. Phys Med Biol. 2006; 51(15):3625-37. DOI: 10.1088/0031-9155/51/15/002. View

Stamatakos G, Zacharaki E, Makropoulou M, Mouravliansky N, Marsh A, Nikita K . Modeling tumor growth and irradiation response in vitro--a combination of high-performance computing and web-based technologies including VRML visualization. IEEE Trans Inf Technol Biomed. 2002; 5(4):279-89. DOI: 10.1109/4233.966103. View

Deisboeck T, Berens M, Kansal A, Torquato S, Stemmer-Rachamimov A, Chiocca E . Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model. Cell Prolif. 2001; 34(2):115-34. PMC: 6495396. DOI: 10.1046/j.1365-2184.2001.00202.x. View

Komarova N . Stochastic modeling of drug resistance in cancer. J Theor Biol. 2005; 239(3):351-66. DOI: 10.1016/j.jtbi.2005.08.003. View

Carlone M, Wilkins D, Nyiri B, Raaphorst P . TCP isoeffect analysis using a heterogeneous distribution of radiosensitivity. Med Phys. 2004; 31(5):1176-82. DOI: 10.1118/1.1711415. View

10.

Goldie J, Coldman A, Ng V, Hopkins H, LOONEY W . A mathematical and computer-based model of alternating chemotherapy and radiation therapy in experimental neoplasms. Antibiot Chemother (1971). 1988; 41:11-20. DOI: 10.1159/000416177. View

11.

McGinn C, Harari P, Fowler J, Ford C, Pyle G, Kinsella T . Dose intensification in curative head and neck cancer radiotherapy--linear quadratic analysis and preliminary assessment of clinical results. Int J Radiat Oncol Biol Phys. 1993; 27(2):363-9. DOI: 10.1016/0360-3016(93)90248-t. View

12.

Brown J . Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation. Br J Radiol. 1979; 52(620):650-6. DOI: 10.1259/0007-1285-52-620-650. View

13.

Dionysiou D, Stamatakos G, Gintides D, Uzunoglu N, Kyriaki K . Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation. Open Biomed Eng J. 2009; 2:43-51. PMC: 2701071. DOI: 10.2174/1874120700802010043. View

14.

Cai Y, Xu S, Wu J, Long Q . Coupled modelling of tumour angiogenesis, tumour growth and blood perfusion. J Theor Biol. 2011; 279(1):90-101. DOI: 10.1016/j.jtbi.2011.02.017. View

15.

Swierniak A, Polanski A, Kimmel M . Optimal control problems arising in cell-cycle-specific cancer chemotherapy. Cell Prolif. 1996; 29(3):117-39. View

16.

Dunst J, Stadler P, Becker A, Lautenschlager C, Pelz T, Hansgen G . Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important. Strahlenther Onkol. 2003; 179(8):521-6. DOI: 10.1007/s00066-003-1066-4. View

17.

Levasseur L, Slocum H, Rustum Y, Greco W . Modeling of the time-dependency of in vitro drug cytotoxicity and resistance. Cancer Res. 1998; 58(24):5749-61. View

18.

Marcu L, van Doorn T, Zavgorodni S, Olver I . Growth of a virtual tumour using probabilistic methods of cell generation. Australas Phys Eng Sci Med. 2003; 25(4):155-61. DOI: 10.1007/BF03178288. View

19.

GRAY L, CONGER A, Ebert M, HORNSEY S, Scott O . The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 1953; 26(312):638-48. DOI: 10.1259/0007-1285-26-312-638. View

20.

Gardner S, Fernandes M . New tools for cancer chemotherapy: computational assistance for tailoring treatments. Mol Cancer Ther. 2003; 2(10):1079-84. View